HK1058366A1 - Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts. - Google Patents

Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts.

Info

Publication number
HK1058366A1
HK1058366A1 HK04101030A HK04101030A HK1058366A1 HK 1058366 A1 HK1058366 A1 HK 1058366A1 HK 04101030 A HK04101030 A HK 04101030A HK 04101030 A HK04101030 A HK 04101030A HK 1058366 A1 HK1058366 A1 HK 1058366A1
Authority
HK
Hong Kong
Prior art keywords
salts
peptide
andpharmaceutical
preparations containing
producing peptide
Prior art date
Application number
HK04101030A
Other languages
English (en)
Inventor
Michael Damm
Waldemar Salonek
Juergen Engel
Horst Bauer
Gabriele Stach
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1058366(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of HK1058366A1 publication Critical patent/HK1058366A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
HK04101030A 2000-08-17 2004-02-13 Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts. HK1058366A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (de) 2000-08-17 2000-08-17 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
PCT/EP2001/009219 WO2002014347A2 (de) 2000-08-17 2001-08-09 Verfahren zur herstellung von peptidsalzen, deren verwendung und die peptidsalze enthaltende pharmazeutische zubereitungen
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (1)

Publication Number Publication Date
HK1058366A1 true HK1058366A1 (en) 2004-05-14

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101030A HK1058366A1 (en) 2000-08-17 2004-02-13 Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts.

Country Status (30)

Country Link
US (1) US6780972B2 (xx)
EP (1) EP1309607B1 (xx)
JP (1) JP2004506647A (xx)
CN (1) CN1187369C (xx)
AR (1) AR030371A1 (xx)
AT (1) ATE280779T1 (xx)
AU (2) AU1043902A (xx)
BG (1) BG107612A (xx)
BR (1) BR0113296A (xx)
CA (1) CA2355573A1 (xx)
CZ (1) CZ2003688A3 (xx)
DE (2) DE10040700A1 (xx)
DK (1) DK1309607T3 (xx)
EE (1) EE200300065A (xx)
ES (1) ES2230371T3 (xx)
HK (1) HK1058366A1 (xx)
HU (1) HUP0300738A3 (xx)
IL (1) IL154150A0 (xx)
MX (1) MXPA03001448A (xx)
NO (1) NO20030618D0 (xx)
NZ (1) NZ524023A (xx)
PL (1) PL204496B1 (xx)
PT (1) PT1309607E (xx)
RU (1) RU2266296C2 (xx)
SI (1) SI1309607T1 (xx)
SK (1) SK3032003A3 (xx)
TW (1) TWI236910B (xx)
UA (1) UA74005C2 (xx)
WO (1) WO2002014347A2 (xx)
ZA (1) ZA200300777B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
RU2525661C2 (ru) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин
CN107056894B (zh) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 一种片段法固相合成醋酸加尼瑞克的方法
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800A (zh) * 2020-09-22 2022-03-29 深圳市星银医药有限公司 一种双羟萘酸多肽药物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
DE3165535D1 (en) * 1980-06-02 1984-09-20 Andrew Victor Schally Lh-rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilization of pharmacoligically active compounds in controlled release compositions.
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
RU2230550C2 (ru) * 1998-01-16 2004-06-20 Такеда Кемикал Индастриз, Лтд. Композиции длительного высвобождения, способ их получения и применение

Also Published As

Publication number Publication date
ZA200300777B (en) 2003-09-18
SI1309607T1 (en) 2005-02-28
TWI236910B (en) 2005-08-01
RU2266296C2 (ru) 2005-12-20
HUP0300738A2 (hu) 2003-09-29
PL359495A1 (en) 2004-08-23
EE200300065A (et) 2004-12-15
IL154150A0 (en) 2003-07-31
PL204496B1 (pl) 2010-01-29
AU2002210439B2 (en) 2005-10-20
BG107612A (bg) 2003-12-31
CN1187369C (zh) 2005-02-02
AU1043902A (en) 2002-02-25
MXPA03001448A (es) 2004-12-13
AR030371A1 (es) 2003-08-20
UA74005C2 (en) 2005-10-17
DK1309607T3 (da) 2005-01-17
WO2002014347A3 (de) 2002-08-08
PT1309607E (pt) 2005-02-28
US20020198146A1 (en) 2002-12-26
JP2004506647A (ja) 2004-03-04
ES2230371T3 (es) 2005-05-01
HUP0300738A3 (en) 2004-08-30
ATE280779T1 (de) 2004-11-15
CZ2003688A3 (cs) 2004-03-17
NO20030618L (no) 2003-02-07
RU2003107560A (ru) 2005-01-27
DE10040700A1 (de) 2002-02-28
WO2002014347A2 (de) 2002-02-21
EP1309607A2 (de) 2003-05-14
NO20030618D0 (no) 2003-02-07
EP1309607B1 (de) 2004-10-27
CN1447817A (zh) 2003-10-08
US6780972B2 (en) 2004-08-24
SK3032003A3 (en) 2004-05-04
NZ524023A (en) 2004-11-26
CA2355573A1 (en) 2003-02-22
DE50104316D1 (de) 2004-12-02
BR0113296A (pt) 2003-07-15

Similar Documents

Publication Publication Date Title
ATE328851T1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
CO5700735A2 (es) Proceso para la preparacion de 2-cianopirrolidinas n-sustituidas
NZ515781A (en) Compositions and methods comprising morphine gluconate
HK1058366A1 (en) Method for producing peptide salts, their use, andpharmaceutical preparations containing these pept ide salts.
CA2235642A1 (en) Processes for preparing sildenafil
WO2000048477A8 (en) Acidic solution of sparingly-soluble group iia complexes
ATE156466T1 (de) Verfahren und mischung zur behandlung von elektrolichtbogenofenstaub
AU2001289849A1 (en) Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
AU2002346825A1 (en) Method for preparing a mixed zinc and manganese oxide
NZ514653A (en) Process for producing an amide compound by reacting a compound with an amino group with a polyaminocarboxylic acid anhydride
ATE261401T1 (de) Verfahren zur industriellen verwendung von muschelschalen
WO2001049605A3 (fr) Procede de preparation de borates de terre rare et utilisation des borates obtenus en luminescence
PL354173A1 (en) Mixture for the treatment of waste materials
BR9911969A (pt) Sal e processos para a preparação de um sal, para a preparação de acetato de n-terc-butilhidroxilamina, para o isolamento de acetato de n-terc- butilhidroxilamina, e para a purificação do acetato de n-terc- butilhidroxilamina
ZA99812B (en) Process for preparing (R)-2-bromo-3-phenyl-propionic acid.
GB0008179D0 (en) Chemical process
HUP0001861A2 (hu) Eljárás kontrasztanyagok előállítására
MXPA05007696A (es) Modificacion cristalina de un complejo de manganeso.
MXPA05006279A (es) Proceso para la preparacion de pregnanos.
HK1061232A1 (en) Method for producing n-substituted hydroxylamines and the salts thereof
UA67941C2 (en) A method for ammonium regeneration from the filtering liquid of ammonium-soda production
AU5643301A (en) Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
RU2000117742A (ru) Способ лечения язвенной болезни
UA42962A (uk) Спосіб одержання нітрату стронцію з апатиту
MXPA03004239A (es) Complejos de metal de acido 2-hidroxi-4-metiltiobutanoico para su uso como alimento para animales.

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100809